You may be eligible to participate in a clinical research study regarding potential future immunotherapy treatments
The INTR@PID CERVICAL 017 Study is a global clinical research study evaluating an investigational drug in patients diagnosed with cervical cancer that cannot be removed surgically and/or has started to spread locally or to other parts of the body. The study is looking at the safety of the investigational drug and whether it works.
You may be eligible to participate in the INTR@PID CERVICAL 017 Study, if you (a) are 18 years of age or older, (b) have been diagnosed with cervical cancer that cannot be removed surgically and/or has spread locally or to another part of the body, and (c) have received treatment with chemotherapy that did not work, or the cancer returned after treatment.
If you take part, you will receive the investigational drug at no cost and your health will be closely monitored at regular study visits.
To learn more about the INTR@PID CERVICAL 017 Study, please visit https://clinicaltrials.emdgroup.com/en/ and contact the study team today.
For information about this trial at the UAMS Winthrop P. Rockefeller Cancer Institute, call 501- 352-9261.